Sotera Health Co Stock Price, News & Analysis

Sotera Health Company (NASDAQ: SHC) announced the departure of CFO Scott Leffler after over five years, effective August 12, 2022, as he relocates to Florida for a new role. The search for a permanent replacement is underway. Leffler's exit is not linked to any operational issues within the company. CEO Michael B. Petras, Jr. expressed gratitude for Leffler's contributions and confidence in the company's future growth, emphasizing its commitment to the mission of safeguarding global health.

Sterigenics has officially launched operations at its newly expanded electron beam (E-beam) facility in Columbia City, Indiana. This expansion aims to enhance sterilization services for medical devices and pharmaceutical products, meeting growing customer demands. The installation of a new E-beam accelerator increases sterilization capacity, ensuring safety for healthcare products. Notably, Sterigenics emphasizes improved productivity, reliability, and safety as part of this facility's upgrade, aligning with its mission of Safeguarding Global Health.

Sotera Health Company (Nasdaq: SHC) reported Q1 2022 net revenues of $237 million, a 12% increase from Q1 2021. Net income rose to $31 million or $0.11 per share, compared to $11 million or $0.04 per share last year. Adjusted EBITDA reached $115 million, up by 10%. The company reaffirmed its 2022 financial outlook, expecting net revenues between $1.0 billion and $1.03 billion. Despite challenges like the Omicron surge and geopolitical issues, Sotera Health emphasized strong execution and strategic capacity building.

Sotera Health Company (Nasdaq: SHC) plans to release its financial results for Q1 2022 on May 5, 2022, before market open. A conference call to discuss the results will take place at 9:00 a.m. Eastern Time. Participants can join by dialing 1-866-777-2509 from the U.S. or 1-412-317-5413 internationally. A live webcast of the call will be available on the company’s Investor Relations website, with a replay accessible later on the same day.

Sotera Health Company (Nasdaq: SHC) has launched the Sotera Health Academy, a new educational platform offering over 100 hours of curated content aimed at supporting MedTech and Pharmaceutical customers. The Academy features more than 150 resources, including webinars and eBooks, created by industry experts from Nelson Labs, Sterigenics, and Nordion. This initiative follows Sotera's acquisition of Regulatory Compliance Associates, enhancing the platform's offerings. The Academy aims to help manufacturers navigate regulatory risks and accelerate product market entry.

Sotera Health Company (Nasdaq: SHC) reported a strong financial performance for Q4 2021, with net revenues increasing by 11.3% to $241 million and a net income of $36 million, recovering from a loss of $44 million in the previous year. For the full year, revenues rose 13.9% to $931 million, with net income of $117 million compared to a loss of $39 million in 2020. The company expects 2022 revenue growth of 7% to 11% and plans significant investments in capacity expansions. Total debt stood at $1.8 billion with a net leverage ratio of 3.5x as of December 31, 2021.

Nelson Labs has launched the Nelson Labs Mark, a verification program aimed at enhancing transparency in product testing, particularly for face masks and respirators. This initiative addresses the rise of fraudulent products during the ongoing COVID-19 pandemic, providing consumers and institutions with reliable data on product performance. The program includes two-factor authentication for product verification and will expand to include other products as needed. This effort is part of Nelson Labs' mission to safeguard global health.

Sotera Health Company (Nasdaq: SHC) will announce its financial results for Q4 and full year ended December 31, 2021, on March 1, 2022, before market open. The company is a leading provider of sterilization solutions and lab testing services for healthcare. Following the announcement, a conference call will take place at 9:00 a.m. ET to discuss operating highlights and results. Interested participants can access the call via a dedicated phone line or through a live webcast on the company’s Investor Relations website.

Sotera Health Company (NASDAQ: SHC) has provided an update on its growth and achievements during the 40th Annual J.P. Morgan Healthcare Conference. The company expects its full-year 2021 revenues to reach between $920 million and $930 million, reflecting a growth of approximately 14% from the previous year. CEO Michael B. Petras, Jr. emphasized the company's strong execution throughout 2021 and shared insights on its long-term growth strategy and ESG initiatives. Full financial results for Q4 and year-end 2021 will be reported on March 1, 2022.